Hematologic Malignancies
📧 Sign up to get email alerts when something new happens for Hematologic Malignancies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: A Second Psilocybin Group Therapy for the Treatment of Cancer-Related Anxiety in Partial Responders With Metastatic Cancer [Phase 1]
Phase 1 trial update examining second psilocybin-assisted group therapy for cancer-related anxiety in partial responders with metastatic can…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Enhanced, EHR-facilitated Cancer Symptom Control Pragmatic Clinical Trial [NA]
A completed pragmatic clinical trial at Mayo Clinic evaluating enhanced, electronic health record–facilitated cancer symptom control; result…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies. [Phase 2]
Phase 2 pediatric trial evaluating GVHD prophylaxis without calcineurin inhibitors after day 60 post first allogeneic hematopoietic stem cel…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Positive Activities Intervention to Improve Quality of Life in Collectivist Culture Cancer Patients and Their Caregivers [NA]
Clinical trial assessing a positive activities intervention to improve quality of life for cancer patients and their caregivers in collectiv…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Survivorship Post-HCT Optimization Program [NA]
Clinical trial update reports the completion of Duke University’s Survivorship Post-HCT Optimization Program trial. The study targets patien…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Study of SUPLEXA in Patients With Metastatic Solid Tumours and Haematologic Malignancies [Phase 1]
Phase 1 study of SUPLEXA in patients with metastatic solid tumors and hematologic malignancies has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy.
A completed clinical trial update examining predictive biomarkers for response and toxicity in patients with hematologic malignancies treate…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia
This entry notes the completion of a clinical trial focused on collecting peripheral blood from patients with hematologic malignancies and t…
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies
This document describes a long-term follow-up study involving subjects who received CRISPR-based CAR T cell therapies; the trial is currentl…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Phase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positive Hematological Malignancies [Phase 1]
Phase I trial update on subcutaneous TQB2825 for CD20-positive hematologic malignancies; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Peer Support Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation [NA]
This update notes that a clinical trial evaluating a peer support intervention for patients undergoing hematopoietic stem cell transplantati…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: VitalTraq for the Detection of CRS [NA]
A completed clinical trial update evaluating VitalTraq for detecting cytokine release syndrome in patients with hematologic malignancies.
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: T Lymphocytes (LT) Expressing iCASP9 and ΔCD19 in Allogeneic Haematopoietic Transplantation. [Phase 1, Phase 2]
Phase 1/2 trial update on T lymphocytes engineered to express iCASP9 and ΔCD19 for allogeneic hematopoietic transplantation; the study statu…
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies [Phase 3]
This clinical trial update covers Expanded Access of Omidubicel for allogeneic transplantation in patients with hematologic malignancies in …
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation [Phase 1]
A Phase 1 clinical trial is evaluating giving chemotherapy for a shortened period before stem cell transplantation in patients with hematolo…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: The Safety and Efficacy of Multiple-dose of WJ01024 in Subject With Advanced Cancer [Phase 1]
Phase 1 clinical trial evaluating multiple doses of WJ01024 in patients with advanced cancer was terminated; the study assessed safety and e…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies [Phase 1]
A Phase 1 trial of AZD0466 as monotherapy or in combination in patients with advanced hematologic malignancies has been terminated, with res…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT [Phase 2]
A Phase 2 trial update reports results for reduced-intensity conditioning and transplantation using HLA-haploidentical hematopoietic cell tr…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Measuring the Impact of MANNA s Medically Tailored Meal Program in Patients With a Non-terminal Cancer Diagnosis
This clinical trial update notes the completed study assessing the impact of MANNA's Medically Tailored Meal Program in patients with non-te…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Food Safety Educational Training Program to Improve Food Safety Knowledge and Behaviors in Cancer Patients Receiving Treatment [NA]
Completed clinical trial evaluating a food safety educational training program designed to improve food safety knowledge and behaviors in ca…
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial of psilocybin-assisted therapy for cancer-related anxiety in patients with metastatic cancer has completed and resu…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma. [Phase 1]
The SG2501 safety study in subjects with relapsed or refractory hematologic malignancies and lymphoma has been terminated (Phase 1).
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Usability, Adherence and Diagnostic Performance of PointCheck in Pediatric Population
A completed clinical trial assessing usability, adherence, and diagnostic performance of PointCheck in pediatric patients with hematologic m…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: AZD4573 in Novel Combinations With Anti-cancer Agents in Patients With Advanced Blood Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial of AZD4573 in novel combinations with anti-cancer agents for advanced hematologic malignancies; results have been p…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Interpretability of the Quantra® Viscoelastic Test in Patients With Haematological Malignancies With Profound Thrombocytopenia Below 50x10 G/L. [NA]
The update reports on the interpretability of the Quantra Viscoelastic Test in patients with hematologic malignancies and severe thrombocyto…